41 related articles for article (PubMed ID: 23313506)
1. Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy.
O'Leary KA; Bates AM; Jin WJ; Burkel BM; Sriramaneni RN; Emma SE; Nystuen EJ; Sumiec EG; Ponik SM; Morris ZS; Schuler LA
Breast Cancer Res; 2023 Jun; 25(1):68. PubMed ID: 37312163
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cells are sensitized by piperine to radiotherapy through estrogen receptor-α mediated modulation of a key NHEJ repair protein- DNA-PK.
Shaheer K; Prabhu BS; Ali HS; Lakshmanan-M D
Phytomedicine; 2024 Jan; 122():155126. PubMed ID: 37913642
[TBL] [Abstract][Full Text] [Related]
3. The different biological effects of single, fractionated and continuous low dose rate irradiation on CL187 colorectal cancer cells.
Wang H; Li J; Qu A; Liu J; Zhao Y; Wang J
Radiat Oncol; 2013 Aug; 8():196. PubMed ID: 23937791
[TBL] [Abstract][Full Text] [Related]
4. RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma.
Thielhelm TP; Nourbakhsh A; Welford SM; Mellon EA; Bracho O; Ivan ME; Telischi F; Fernandez-Valle C; Dinh CT
Otolaryngol Head Neck Surg; 2022 Nov; 167(5):860-868. PubMed ID: 35230908
[TBL] [Abstract][Full Text] [Related]
5. Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts.
Ji J; Dragojevic S; Callaghan CM; Smith EJ; Talele S; Zhang W; Connors MA; Mladek AC; Hu Z; Bakken KK; Sarkaria PP; Carlson BL; Burgenske DM; Decker PA; Rashid MA; Jang MH; Gupta SK; Eckel-Passow JE; Elmquist WF; Sarkaria JN
Mol Cancer Ther; 2024 May; 23(5):662-671. PubMed ID: 38224566
[TBL] [Abstract][Full Text] [Related]
6. New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma.
Perez-Lanzon M; Carbonnier V; Cordier P; De Palma FDE; Petrazzuolo A; Klein C; Arbaretaz F; Mangane K; Stoll G; Martins I; Fohrer Ting H; Paillet J; Mouillet-Richard S; Le Corre D; Xiao W; Sroussi M; Desdouets C; Laurent-Puig P; Pol J; Lopez-Otin C; Maiuri MC; Kroemer G
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344100
[TBL] [Abstract][Full Text] [Related]
7. Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
Michmerhuizen AR; Lerner LM; Ward C; Pesch AM; Zhang A; Schwartz R; Wilder-Romans K; Eisner JR; Rae JM; Pierce LJ; Speers CW
Br J Cancer; 2022 Sep; 127(5):927-936. PubMed ID: 35618789
[TBL] [Abstract][Full Text] [Related]
8. Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer.
Ding J; Cao Y; Guo Y
Front Oncol; 2022; 12():832763. PubMed ID: 35494071
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models.
Michmerhuizen AR; Lerner LM; Pesch AM; Ward C; Schwartz R; Wilder-Romans K; Liu M; Nino C; Jungles K; Azaria R; Jelley A; Zambrana Garcia N; Harold A; Zhang A; Wharram B; Hayes DF; Rae JM; Pierce LJ; Speers CW
NPJ Breast Cancer; 2022 Mar; 8(1):31. PubMed ID: 35273179
[TBL] [Abstract][Full Text] [Related]
10. Targeted and systemic insights into the crosstalk between DNA-dependent protein kinase catalytic subunit and receptors of estrogen, progesterone and epidermal growth factor in the context of cancer.
Ansari SMR; Hijazi FS; Souchelnytskyi S
Mol Biol Rep; 2022 Jan; 49(1):587-594. PubMed ID: 34731368
[TBL] [Abstract][Full Text] [Related]
11. Modulating the Radiation Response for Improved Outcomes in Breast Cancer.
Pesch AM; Pierce LJ; Speers CW
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250414
[No Abstract] [Full Text] [Related]
12. Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review.
Ding J; Guo Y; Jiang X; Li K; Fu W; Cao Y
Medicine (Baltimore); 2020 Jul; 99(30):e21344. PubMed ID: 32791733
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor Signaling in Radiotherapy: From Molecular Mechanisms to Clinical Studies.
Rong C; Meinert ÉFRC; Hess J
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498642
[TBL] [Abstract][Full Text] [Related]
14. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
[TBL] [Abstract][Full Text] [Related]
15. Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs.
Dolfi SC; Jäger AV; Medina DJ; Haffty BG; Yang JM; Hirshfield KM
Cancer Lett; 2014 Aug; 350(1-2):52-60. PubMed ID: 24747123
[TBL] [Abstract][Full Text] [Related]
16. Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells.
Wang J; Yang Q; Haffty BG; Li X; Moran MS
Biochem Biophys Res Commun; 2013 Feb; 431(2):146-51. PubMed ID: 23313506
[TBL] [Abstract][Full Text] [Related]
17. [Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells].
Feng H; Guo B; Kong X; Wu B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):940-4. PubMed ID: 27363277
[TBL] [Abstract][Full Text] [Related]
18. Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair.
Alonso-González C; González A; Martínez-Campa C; Gómez-Arozamena J; Cos S
J Pineal Res; 2015 Mar; 58(2):189-97. PubMed ID: 25623566
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-dependent regulation of Eg5 in breast cancer cells.
Planas-Silva MD; Filatova IS
Anticancer Drugs; 2007 Aug; 18(7):773-9. PubMed ID: 17581299
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
